Georgia DUI-Drugs Defense Lawyer for contested impairment cases.

A Georgia DUI-drugs prosecution looks, on paper, like a DUI-alcohol case. It is not. The statute the State charges, the science it leans on, and the inferences it asks a jury to draw all operate on different ground — and that ground is where a contested case is actually tried.

IThe statute

Georgia prosecutes drug DUI under O.C.G.A. § 40-6-391. Subsection (a)(2) requires the State to prove the driver was under the influence of any drug to the extent that it is less safe for the person to drive. Subsection (a)(6) addresses driving with marijuana or a controlled substance present in the blood or urine, but its reach has been substantially narrowed by Georgia case law for lawful medical-marijuana users. In most contested DUI-drugs cases, the real burden remains the less-safe theory: not presence, but impairment at the time of driving.

IIThe pharmacology gap

Alcohol pharmacokinetics behave linearly enough that a blood alcohol concentration can be extrapolated to the time of driving with defensible assumptions. THC does not. Delta-9-THC peaks within minutes of inhalation, redistributes rapidly into fatty tissue, and declines even as a person remains functionally impaired. By the time of a blood draw — frequently one to three hours after the stop — delta-9 levels may have fallen substantially, while the inactive carboxy-THC metabolite may persist for days or weeks in regular users. The peer-reviewed literature is unambiguous: there is no scientifically validated blood concentration of THC that correlates reliably with driving impairment.

Prescription medications carry their own pharmacological complications — half-lives, active metabolites, individual tolerance, and the difference between therapeutic and impairing levels. The State's chemist, examined patiently, frequently concedes more than the prosecutor expects.

IIIThe stop and the field investigation

A typical DUI-drugs investigation follows a familiar shape: a traffic infraction, an odor of cannabis or admission to use, watery or bloodshot eyes, statements, and field sobriety testing. Every link in that chain is contestable. Odor of cannabis, post-hemp legalization, no longer establishes probable cause the way it once did. Bloodshot eyes are consistent with fatigue, allergies, contact lenses, and an LED flashlight at close range. Statements are routinely paraphrased in reports in ways materially different from what the body-worn camera captured.

IVSFSTs and the DRE protocol

The Standardized Field Sobriety Tests were validated for alcohol — not cannabis, not benzodiazepines, not opioids. Drug Recognition Evaluations are presented as if they were clinical assessments. They are not. The twelve-step DRE protocol was developed by law enforcement, validated against laboratory toxicology rather than driving performance, and its predictive value for impairment on the road has never been established to the standard a peer-reviewed scientific instrument would require. That does not make DRE testimony inadmissible. It does make it cross-examinable.

VFrom the courtroom

The firm has tried a DUI-drugs case in which the State alleged marijuana use shortly before driving and offered positive toxicology findings. The jury returned a not-guilty verdict. The case was not won by attacking the chemistry alone. It was won by isolating the gap between what the lab measured and what the State asked the jury to infer from that measurement — a gap the State's witnesses, when examined patiently, were unable to close. That outcome is not promised in any other case. It is offered because it illustrates what a DUI-drugs trial actually requires: preparation against the science, discipline at the lectern, and a defense that does not overreach.

VIHemp, odor, and probable cause

Federal hemp legalization in 2018 and the Georgia Hemp Farming Act materially changed the probable-cause landscape. Hemp and marijuana are visually indistinguishable and produce the same olfactory signature on burn or in raw form. Georgia courts and trial judges have increasingly required officers to articulate facts beyond odor to establish probable cause — particularly for searches of vehicles, containers, and persons. A defense built around the odor-only stop frequently survives the motion. When it survives the motion, the case is over before voir dire.

VIIBlood draws, warrants, and implied consent

Warrantless blood draws in Georgia DUI cases are governed by Williams v. State, the Fourth Amendment, and a developed line of authority on consent and exigency. The implied-consent statute does not, by itself, supply constitutionally valid consent. The advisement must be timely, accurate, and made in circumstances that permit a meaningful choice. A defendant told that a refusal will result in license consequences but not told that the State intends to seek a warrant is in a different position than a defendant fully informed. The body-worn camera, the dashcam, and the phlebotomy record are where that distinction is litigated.

VIIIGBI toxicology, methodology, and discovery

The Georgia Bureau of Investigation Division of Forensic Sciences performs cannabinoid confirmation by liquid chromatography–tandem mass spectrometry. The report typically distinguishes delta-9-THC (psychoactive), 11-hydroxy-THC (active metabolite), and 11-nor- 9-carboxy-THC (inactive metabolite). Carboxy-THC can persist for days or weeks in regular users and is not, by itself, evidence of recent impairment. The certificate the State offers at trial rarely discloses limits of detection, limits of quantitation, calibration history, internal QC trends, or the analyst's bench notes. The defense obtains those materials on request. They are frequently where the case actually opens.

IXPolysubstance and prescription-medication allegations

Many DUI-drugs prosecutions involve more than one substance — alcohol and a prescribed benzodiazepine, cannabis and a prescribed opioid, stimulants and antidepressants. The pharmacology of combined exposure is real and well documented; it is also individualized in ways the State's chemist cannot quantify for a specific defendant on a specific night. Prescription cases turn on whether the medication was taken as directed, what the prescribing physician knew, what the defendant's tolerance was, and whether the toxicology values are consistent with therapeutic or supratherapeutic levels. None of that appears on the State's certificate.

XWhat a contested DUI-drugs trial actually looks like

From the lectern, a contested DUI-drugs jury trial is a sequence of small, careful concessions extracted from the State's own witnesses. The officer concedes the limits of the field battery. The DRE concedes the validation environment. The chemist concedes presence is not impairment, and that the blood draw was not at the time of driving. The closing argument writes itself: the State measured something, but the State did not measure what it charged.

XIWhere to read more

• Defending Marijuana DUI Allegations in Georgia
• The Limits of SFSTs in a Drug DUI Prosecution
• THC Blood Testing in Georgia: GBI Methodology
• Cross-Examining a Toxicologist in a Georgia DUI-Drugs Trial
• Polysubstance DUI Defense in Georgia
• Fourth Amendment Traffic Stops in Georgia

Prior results do not guarantee a similar outcome. Nothing in this analysis constitutes legal advice.